| ATOS | 60.20 / +2.07% |
| Date/Time | 04/09 / 17:35 |
| Chg. / Chg.(%) | 1.22 / +2.07% |
| Bid | 60.10 / 50 |
| Ask | 60.52 / 45 |
| Open | 59.12 |
| Previous Close | 58.98 |
| High | 60.80 |
| Low | 58.66 |
| Volume [EUR] | 66,314,810.50 |
| Volume [Units] | 1,104,787 |
| Price fixings | 12676 |
| ISIN | FR0000051732 |
| Security | ATO |
| Exchange | Euronext - Paris |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 60.160 |  |
|
| Euronext - P.. | 60.20 |  |
1,104,787 |
| Cboe Europe .. | 60.50 | |
396,773 |
| Turquoise | 60.50 | |
161,843 |
| London Inter.. | 60.55 | |
67,287 |
| Vienna Globa.. | 60.44 | |
4,883 |
| TradeGate | 60.440 | |
2,880 |
| Cboe Europe .. | 60.40 | |
2,570 |
| Frankfurt | 59.9400 | |
1,452 |
| gettex | 60.260 | |
1,042 |
| Cboe Europe .. | 60.53 | |
1,014 |
| München | 60.00 | |
100 |
| Berlin | 58.78 | |
0 |
| Düsseldorf | 60.02 | |
0 |
| Stuttgart | 60.480 | |
0 |
| Nasdaq Other.. | 67.6342 | 599 | |
| EUREX | Options | ||
News
- Atos SE Investors: Company Investigated by the Portnoy Law Firm
04/09/2021 / 20:26 - GlobeNewswire - Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway
04/08/2021 / 15:30 - GlobeNewswire - New Study from Arkose Labs Reveals that Businesses Underestimate Full Impact of Account Takeover Attacks
04/08/2021 / 14:00 - GlobeNewswire - Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
03/31/2021 / 15:30 - GlobeNewswire - Europe opens higher as Suez blockage nears end
03/29/2021 / 09:06 - TeleTrader
Real-time